Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD - Concepedia

Concepedia

Publication | Closed Access

Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD

347

Citations

19

References

2005

Year

Antony Bayer, R. Morris Bullock, Roy Jones, David Wilkinson, K. R. Paterson, Lisa Jenkins, S. Babli Millais, Stephen Donoghue

Abstract

AN1792 + QS-21 elicited a positive antibody response to Abeta42 in more than half of this elderly study population.

References

	Year	Citations

Page 1